Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cosopt vs Timolol in Glaucoma or Ocular Hypertension
NCT00108017Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Apr 2005
- Primary completion
- Jul 2006
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of dorzolamide + timolol in Open-angle glaucoma (OAG), ocular hypertension, sponsored by Merck & Co.. Started Apr 2005; status: completed.
02
Drugs
dorzolamide + timolol
03
Conditions
Open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00108017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00108017.